Chris Scotti is a Senior Managing Director of Institutional Equities at Leerink Partners.
Prior to joining the Firm in 2024, Mr. Scotti served as an Executive Director in the Institutional Sales division at Morgan Stanley. Mr. Scotti built a significant franchise in the Biotech and MedTech verticals with public and private healthcare investors during a career spanning more than 20 years. While at Morgan Stanley, Mr. Scotti led and supported multiple prime brokerage mandates and swap relationships in the healthcare sector. Working closely with Healthcare Investment Banking and Capital Markets teams, Mr. Scotti was a key contributor to the TTW and IPO process that supported Morgan Stanley’s top league table rankings. Prior to Morgan Stanley, Mr. Scotti spent 10 years at UBS covering institutional and high-net-worth clients and began his career as a Vice President at Gabelli & Company.
Mr. Scotti earned a Bachelor’s degree in Finance with a minor in Marketing from the University of Rhode Island and an MBA in Finance from Fordham University.